Preoperative treatment of spasticity with botulinum neurotoxin A to reduce pain in cerebral palsy: is it worthwhile?

Dev Med Child Neurol. 2019 Sep;61(9):997. doi: 10.1111/dmcn.14191. Epub 2019 Feb 14.
No abstract available

Publication types

  • Comment

MeSH terms

  • Botulinum Toxins, Type A*
  • Cerebral Palsy*
  • Child
  • Double-Blind Method
  • Humans
  • Muscle Spasticity
  • Neuromuscular Agents*
  • Pain

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A